Photopharmacology is an area based on the creation of chemical compounds able to control the functioning of biological molecules using light. Photochromic compounds which activate or inhibit the activity of key cellular proteins, particularly ion channels, depending on the wavelength of the light, are powerful tools for noninvasive control of neural networks and, thus, for controlling the organs and behavior of animals. Photochromic substances can be divided into two main classes: (a) soluble photochromic ligands and (b) compounds covalently binding to target proteins, or tethered photochromic ligands. Potassium channel blockers, modulators of glutamate and GABA receptors, and cationic TRP channels have been created on this basis. Photopharmacology opens up the potential for controlling pain, restoring the photosensitivity of the retina, and controlling other physiological functions. This minireview will briefly present the main principles of the organization and actions of light-controlled switches, along with a description of photochromic chemical compounds able to modulate the activity of voltage-gated ion channels, and present preliminary investigations on the creation of photopharmacological compounds for therapeutic use.
Similar content being viewed by others
References
Banghart, M. R., Mourot, A., Fortin, D. L., et al., “Photochromic blockers of voltage-gated potassium channels,” Angewandte Chemie Int. Ed. 48, 9097–9101 (2009).
Banghart, M., Borges, K., Isacoff, E., et al., “Light-activated ion channels for remote control of neuronal firing,” Nat. Neurosci., 7, 1381–1386 (2004).
Berg, J., Hung, Y. P., and Yellen, G., “A genetically encoded fluorescent reporter of ATP: ADP ratio,” Nat. Methods, 6, 161–6 (2009).
Bilan, D. S., Pase, L., Joosen, L., et al., “HyPer-3: a genetically encoded H2O2 probe with improved performance for ratiometric and fluorescence lifetime imaging,” ACS Chem. Biol., 8, 535–42 (2013).
Bregestovski, P. and Mukhtarov, M., “Optogenetics: perspectives in biomedical research (review),” Sovrem. Tekhnol. Med., 8, No. 4, 212–21 (2016).
Bregestovski, P. D., “Optogenetics in neurology: review of directions and perspectives,” in: Neurology in the 21st Century: Diagnostc, Therapeutic, and Research Techniques, Vol 3, Current Research Techniques in Experimental Neurology, M. A. Piradov et al. (eds.), ATMO, Moscow (2015), pp. 315–349.
Bregestovski, P., “Architecture of receptor-operated ion channels of biological membranes,” Biophysics, 56, No. 1, 51–64 (2011).
Bregestovski, P., Waseem, T., and Mukhtarov, M., “Genetically encoded optical sensors for monitoring of intracellular chloride and chloride-selective channel activity,” Front. Mol. Neurosci., 2, No. 15 (2009).
Buckingham, S. D., Kidd, J. F., Law, R. J., et al., “Structure and function of two-pore-domain K+ channels: contributions from genetic model organisms,” Trends. Pharmacol. Sci., 26, No. 7, 361–367 (2005).
Busskamp, V., Duebel, J., Balya, D., et al., “Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa,” Science, 329, 413–417 (2010).
Chambers, J. J, Banghart, M. R., Trauner, D., and Kramer, R. H., “Light-induced depolarization of neurons using a modified Shaker K+ channel and a molecular photoswitch,” J. Neurophysiol., 96, No. 5, 2792–2796 (2006).
Choi, K. L., Mossman, C., Aubé, J., and Yellen, G., “The internal quaternary ammonium receptor site of Shaker potassium channels,” Neuron, 10, No. 3, 533–541 (1993).
Covington, H. E., Lobo, M. K., Maze, I., et al., “Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex,” J. Neurosci., 30, 16082–16090 (2010).
Doyle, D. A., Morais Cabral, J., Pfuetzner, R. A., et al., “The structure of the potassium channel: molecular basis of K+ conduction and selectivity,” Science, 280, 69–77 (1998).
Firsov, M. L., “Perspectives for the optogenetic prosthetization of the retina,” Zh. Vyssh. Nerv. Deyat., 67, No. 5 (2017).
Fortin, D. L., Banghart, M. R., Dunn, T. W., et al., “Photochemical control of endogenous ion channels and cellular excitability,” Nat. Meth., 5, No. 4, 331–338 (2008).
Fortin, D. L., Dunn, T. W., and Kramer, R. H., “Engineering light-regulated ion channels,” Cold Spring Harb. Protoc., 2011, No. 6, 579–585 (2011).
Fritzsche, J., “Note sur les carbures d’hydrogène solides, tirés du gaudron de houille,” C.R. Acad. Sci., 69, 1035–1037 (1867).
Gaub, B. M., Berry, M. H., Holt, A. E., et al., “Optogenetic vision restoration using rhodopsin for enhanced sensitivity,” Mol. Ther., 23, No. 10, 1562–1571 (2015).
Gorostiza, P., Arosio, D., and Bregestovski, P., “Molecular probes and switches for functional analysis of receptors, ion channels and synaptic networks,” Front. Mol. Neurosci., 6, 48 (2013).
Harvey, A. J. and Abell, A. D., “α-Ketoester-based photobiological switches: synthesis, peptide chain extension and assay against α-chymotrypsin,” Bioorg. Med. Chem. Lett., 11, No. 18, 2441–2444 (2001).
Haubensak, W., Kunwar, P. S., Cai, H., et al., “Genetic dissection of an amygdala microcircuit that gates conditioned fear,” Nature, 468, 270–276 (2010).
Häusser, M., “Optogenetics: the age of light,” Nat. Methods, 11, 1012–1014 (2014).
Hirshberg, Y., “Photochromie dans la serie de la bianthrone,” C.R. Acad. Sci., 231, No. 18, 903–904 (1950).
Imamura, H., Nhat, K. P. H., Togawa, H., et al., “Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators,” Proc. Natl. Acad. Sci. USA, 106, 15651–15656 (2009).
Janovjak, H., Szobota, S., Wyart, C., et al., “A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing,” Nat. Neurosci., 13, No. 8, 1027–1032 (2010).
Kokel, D., Cheung, C. Y. J., Mills, R., et al., “Photochemical activation of TRPA1 channels in neurons and animals,” Nat. Chem. Biol., 9, No. 4, 257–63 (2013).
Kramer, R. H., Mourot, A., and Adesnik, H., “Optogenetic pharmacology for control of native neuronal signaling proteins,” Nat. Neurosci., 16, 816–23 (2013).
Kuang, Q., Purhonen, P., and Hebert, H., “Structure of potassium channels,” Cell. Mol. Life Sci., 72, No. 19, 3677–3693 (2015).
Laprell, L., Hüll, K., Stawski, P., et al., “Restoring light sensitivity in blind retinae using a photochromic AMPA receptor agonist,” ACS Chem. Neurosci., 7, 15–20 (2015).
Lima, S. Q. and Miesenböck, G., “Remote control of behavior through genetically targeted photostimulation of neurons,” Cell, 121, No. 1, 141–152 (2005).
Macé, E., Caplette, R., Marre, O., et al., “Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice,” Mol. Ther., 23, 7–16 (2014).
MacKinnon, R. and Yellen, G., “Mutations affecting TEA blockade and ion permeation in voltage-activated K+ channels,” Science, 250, No. 4978, 276–279 (1990).
MacKinnon, R., “Potassium channels,” FEBS Lett., 555, No. 1, 62–65 (2003).
Miesenböck, G., “Optogenetic control of cells and circuits,” Annu. Rev. Cell Dev. Biol., 27, 731–58 (2011).
Mourot, A., Kienzler, M. A., Banghart, M. R., et al., “Tuning photochromic ion channel blockers,” ACS Chem. Neurosci., 2, No. 9, 536–43 (2011).
Polosukhina, A., Litt, J., Tochitsky, I., et al., “Photochemical restoration of visual responses in blind mice,” Neuron, 75, No. 2, 271–82 (2012).
Rossi, M. A., Calakos, N., and Yin, H. H., “Spotlight on movement disorders: what optogenetics has to offer,” Mov. Disord., 30, 624–631 (2015).
Sahel, J. A. and Roska, B., “Gene therapy for blindness,” Annu. Rev. Neurosci., 36, 467–488 (2013).
Sandoz, G. E. and Levitz, J., “Optogenetic techniques for the study of native potassium channels,” Front. Mol. Neurosci., 6, 6 (2013).
Sandoz, G., Levitz, J., Kramer, R. H., and Isacoff, E. Y., “Optical control of endogenous proteins with a photoswitchable conditional subunit reveals a role for TREK1 in GABA B signaling,” Neuron, 74, No. 6, 1005–1014 (2012).
Stawski, P., Sumser, M., and Trauner, D., “A photochromic agonist of AMPA receptors,” Angewandte Chemie International Edition, 51, 5748–5751 (2012).
Szobota, S., Gorostiza, P., Del Bene, F., et al., “Remote control of neuronal activity with a light-gated glutamate receptor,” Neuron, 54, No. 4, 535–545 (2007).
Tochitsky, I., Polosukhina, A., Degtyar, V. E., et al., “Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells,” Neuron, 81, No. 4, 800–813 (2014).
Tye, K. M. and Deisseroth, K., “Optogenetic investigation of neural circuits underlying brain disease in animal models,” Nat. Rev. Neurosci., 13, 251–66 (2012).
Velema, W. A., Szymanski, W., and Feringa, B. L., “Photopharmacology: beyond proof of principle,” J. Am. Chem. Soc., 136, 2178–2191 (2014).
Wagner, F. B., Truccolo, W., Wang, J., and Nurmikko, A. V., “Spatiotemporal dynamics of optogenetically induced and spontaneous seizure transitions in primary generalized epilepsy,” J. Neurophysiol., 113, No. 7, 2321–2341 (2015).
Wang, F., Bélanger, E., Paque, M. E., et al., “Probing pain pathways with light,” Neuroscience, 338, 248–271 (2016).
Williams, J. C. and Denison, T., “From optogenetic technologies to neuromodulation therapies,” Sci. Transl. Med., 5, No. 177 (2013).
Yamamoto, K., Tanei, Z. I., Hashimoto, T., et al., “Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease,” Cell Rep., 11, No. 6, 859–865 (2015).
Yue, L., Pawlowski, M., Dellal, S. S., et al., “Robust photoregulation of GABA(A) receptors by allosteric modulation with a propofol analogue,” Nat. Commun., 3, 1095 (2012).
Zhou, M., Morais-Cabral, J. H., Mann, S., and MacKinnon, R., “Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors,” Nature, 411, No. 6838, 657–661 (2001).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Vysshei Nervnoi Deyatel’nosti imeni I. P. Pavlova, Vol. 67, No. 5, pp. 41–52, September–October, 2017.
Rights and permissions
About this article
Cite this article
Bregestovski, P.D., Maleeva, G.V. Photopharmacology: A Brief Review Using the Control of Potassium Channels as an Example. Neurosci Behav Physi 49, 184–191 (2019). https://doi.org/10.1007/s11055-019-00713-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-019-00713-3